Skip to content
Screener

RenovoRx RNXT Q1 2025 Annual earnings

Reported May 15, 2025 · After market close

Revenue$197.0KBeat by $13.7K
EPS-$0.08In line
Revenue estimate$183.3K
EPS estimate-$0.08

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$952.0K
EPS estimate-$0.05

FAQ

When did RenovoRx report Q1 2025 earnings?
RenovoRx (RNXT) reported Q1 2025 earnings on May 15, 2025 after market close.
What were RenovoRx's Q1 2025 revenue and EPS?
RenovoRx reported revenue of $197.0K and eps of $-0.08 for Q1 2025.
Did RenovoRx beat estimates in Q1 2025?
Revenue beat the consensus estimate of $183.3K by $13.7K. EPS beat the consensus estimate of $-0.08 by $0.00.
How did RenovoRx's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 14.3% from $-0.07.
Where can I find RenovoRx's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001641172-25-010895) and the 10-K periodic report (0001641172-25-001932) directly on SEC EDGAR. The filing index links above go to sec.gov.